Nasal delivery of parasiticides
US6764999B2 · kind B2 · utility
3Cited by
13References
13Claims
0Family size
Inventors
Key dates
| Filing date | Jul 11, 2002 |
| Grant date | Jul 20, 2004 |
| Priority date | — |
| Expiry date | Jul 11, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method to treat an animal in need thereof with one or more parasiticides by administering those one or more parasiticides to the nasal pharynx of the animal. A method to increase an animal's blood levels of one or more avermectin compounds/milbemycin compounds such that the blood levels of those one or more avermectin compounds/milbemycin compounds reach a maximum concentration in about 24 hours, and such that those blood levels exceed about 2 ng/ml for at least 96 hours post administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.